Viruses That Can Cure, When Antibiotics Fail...
- *Corresponding Author:
- Verbeken G
Laboratory for Molecular and Cellular Technology
Burn Wound Centre, Queen Astrid Military Hospital
Bruynstraat, Brussel, Belgium
Tel: + 32 2 264 4856
E-mail: [email protected]
Received Date: December 03, 2015; Accepted Date: December 15, 2015; Published Date: December 22, 2015
Citation: Verbeken G, Pirnay JP, Lavigne R, Ceulemans C, De Vos D, et al. (2016) Viruses That Can Cure, When Antibiotics Fail…. J Microb Biochem Technol 8: 021- 024. doi:10.4172/1948-5948.1000257
Copyright: © 2015 Verbeken G, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Resistance of bacteria to antibiotics just keeps growing. Industry’s antibiotic pipeline is running dry. Before the pharmaceutical development of antibiotics, natural bacteriophages (=bacterial viruses) were commercialised and used to kill pathogenic bacteria. This therapeutic application of natural bacteriophages was called “bacteriophage therapy”. Today, countries like Poland, Georgia and Russia are still practising bacteriophage therapy. The European Union and “modern” medicine as a whole needs an urgent return of bacteriophage therapy as part of its armamentarium to fight bacterial resistance to antibiotics. This paper reflects on the issue and proposes a European regulatory frame that could fit the re-introduction of bacteriophage therapy without losing sight of safety, quality and efficacy aspects.